Inhaled CpG increases survival and synergizes with checkpoint inhibition in lymphangioleiomyomatosis.

Mayowa M Amosu,Jacob C McCright, Bennett E Yang, Juan Grano de Oro Fernandez, Kaitlyn A Moore,Havish S Gadde, Michele L Kaluzienski,Katharina Maisel

bioRxiv : the preprint server for biology（2023）

引用 0|浏览0

暂无评分

摘要

We have found that TLR9 agonist CpG can be used as LAM immunotherapy and effectively synergizes with anti-PD1 therapy in LAM.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要